CALIDI BIOTHERAPEUTICS INC (CLDI)
US3207031010 - Common Stock
CLDI Stock Earnings: Calidi Biotherapeutics Beats EPS for Q1 2024
CLDI stock results show that Calidi Biotherapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results
Calidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting
Which stocks are experiencing notable movement on Monday?
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24
Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering
BZFD Stock: BuzzFeed Is Prepping for a Reverse Stock Split
BuzzFeed stock is falling on Tuesday after the media company announced plans for a reverse stock split to boost the price of BZFD shares.
Why Is Calidi Biotherapeutics (CLDI) Stock Down 51% Today?
Calidi Biotherapeutics stock is falling hard on Tuesday after the company priced a public offering for more than 15 million shares of CLDI.
Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Pre-market stock movers are worth diving into on Tuesday as we check out all of the biggest changes and the news behind them!
CLDI Stock Earnings: Calidi Biotherapeutics Misses EPS for Q4 2023
CLDI stock results show that Calidi Biotherapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Operating and Financial Results
Calidi Biotherapeutics and City of Hope Announce Funding from the California Institute for Regenerative Medicine (CIRM) to Advance CLD-101 (NeuroNova) in Ovarian Cancer
Calidi Biotherapeutics to Highlight Novel Systemic Enveloped Oncolytic Virotherapy Platform Designed to Target All Tumor Sites at Upcoming Conference
Calidi Biotherapeutics files to sell 10M shares, 10M warrants (NYSE:CLDI)
Calidi Biotherapeutics files a prospectus for the sale of 10M shares and warrants, clarifying it is not an offer to sell securities.
Calidi Biotherapeutics Announces the Appointment of Three New Members to its Scientific and Medical Advisory Board
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to dive into the biggest pre-market stock movers with all of the latest coverage worth reading about on Wednesday morning!